Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vascular Solutions

Explore full profile

Specialized medical devices for minimally invasive vascular procedures

Maple Grove, United StatesFounded 1997Health Tech & Medtech
Valuation $1.00B Market cap · 2016
Revenue $100–500M Latest reported FY

About Vascular Solutions

Vascular Solutions, Inc. was a medical device company established in 1997 by Howard Root and Dr. Gary Gershony, who invented the company's inaugural product, the Duett arterial puncture sealing device. Based in Minneapolis, the company focused on developing and marketing clinical solutions for minimally invasive coronary and peripheral vascular procedures. Its business model centered on creating niche products that often faced little competition from larger industry players. The product portfolio grew to include over 90 proprietary items sold to interventional cardiologists, radiologists, electrophysiologists, and vein specialists through a direct U.S. sales force and an international distributor network.

Howard Root, a lawyer by training, served as the company's CEO for its entire 20-year history, guiding it from a startup to a business with over 550 employees. The company went public in 2000 and consistently generated double-digit annual revenue growth. A significant event in the company's history was a five-year legal battle with the U.S. Department of Justice over allegations of off-label promotion, which concluded in February 2016 with the acquittal of the company and Root.

In December 2016, Teleflex Incorporated announced its definitive agreement to acquire Vascular Solutions for approximately $1.0 billion. The acquisition was completed in the first half of 2017, and Vascular Solutions became a part of Teleflex. The deal was intended to expand Teleflex's entry into the coronary and peripheral vascular markets and leverage its global distribution network to enhance the reach of Vascular Solutions' products. Following the acquisition, the Vascular Solutions brand and operations were integrated into Teleflex's broader portfolio of vascular access and interventional products.

Source: Dealroom company data

At a glance

Status
Listed
Founded
1997
Headquarters
Maple Grove, United States
Listing
IPO 2008
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tier

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • OVP Venture Partners
  • Tredegar Investments

Series B and later2 investors entered at this stage

  • Tredegar Investments
  • OVP Venture Partners
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States92.1%
🇮🇳 India3.2%
🇮🇹 Italy1.6%
🇦🇹 Austria1.6%
🇩🇪 Germany1.6%
5 countries shown

Patents

Estimated portfolio value
$33M

26 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vascular Solutions on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vascular Solutions on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.